This activity is sponsored by The Ponce Medical School Foundation, Inc. and the American College of Cardiology Puerto Rico Chapter.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Ponce Medical School Foundation, Inc., and American College of Cardiology Puerto Rico Chapter. The Ponce Medical School Foundation, Inc is accredited by the Accreditation Council for Continuing Medical Education (ACCME), Provider’s No. 0007249, to provide continuing medical education for physicians. The Ponce Medical School Foundation, Inc is accredited by the Puerto Rico Board of Licensing and Medical Disciplines, provider’s No. 016-DC23-JLDM.
Credit Designation
The Ponce Medical School Foundation, Inc designate this educational activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Policy
It is the policy of Ponce Medical School Foundation, Inc to ensure independence, balance, objectivity, scientific rigor and integrity in all of its sponsored educational activities.
All persons who are in a position to control the educational content of a sponsored activity are expected to disclose to the participants any relevant financial relationship(s) they have with the commercial supporters and/or providers of commercial services and/or manufacturers of any commercial products discussed during the educational activity. All conflicts of interest have been identified and resolved prior to the release of this activity.
The Puerto Rico Chapter of the American College of Cardiology, on its 33rd Meeting, will provide the most updated information regarding the management of basic and complex cardiovascular diseases and practice improvement. A well-balanced scientific program has been developed, emphasizing appropriateness of care in patients with progressive and cardiovascular diseases and other relevant conditions carrying significant morbidity and mortality in our population. Also, will highlight the application of current guidelines, existing and new technologies, and breakthroughs in the management and prevention of cardiovascular diseases.
Learning Objectives:
At the end of the program the participant should be able to:
Updates in atrial fibrillation management
Appropriate use of antiarrhythmic therapies
Transcatheter Tricuspid Valve Therapies
Transcatheter Mitral Valve Therapies
Pre-procedural planning with cardiac CT for structural heart disease
Updates in TAVR management
Improving quality of life of patients with cardiovascular diseases
Cardiac emergencies in pregnancy
Coronary artery disease in women
Management of stable coronary artery disease: Controversy Regarding Revascularization
Heart failure: cardiogenic shock management
Review the importance of precision in determining the type of cardiac amyloidosis
Upon booking a credit card will be required to charge a Non-refundable deposit of one night with taxes.
Cut-off Date – April 6, 2023. Any reservation requested after April 6, 2023,will be subject to availability and it will be at a higher rate than the one contracted for the Convention.
Upon booking a credit card will be required to charge a Non-refundable deposit of one night with taxes.
Cut-off Date – April 6, 2023. Any reservation requested after April 6, 2023,will be subject to availability and it will be at a higher rate than the one contracted for the Convention.
Welcoming Remarks Héctor J. Martínez González, MD FACC
President & Governor ACC PR Chapter Karen Rodríguez Maldonado, MD FACC
President Scientific Program Committee
8:00am
SESSION 1 – ATRIAL FIBRILLATION MANAGEMENT
Management of subclinical and device-detected atrial fibrillation Miguel Leal, MD
Anticoagulation after LAAO Helder Hernández, MD
Updates in Management of Atrial Fibrillation Miguel Leal, MD
Wearable technology Juan C Sotomonte, MD
Q & A
9:30am
Break & Exhibit Viewing
10:00am
SESSION 2 – ABLATION
Cryoablation vs radiofrequency ablation pulmonary vein isolation Parikshit Sharma, MD
The future of cardiac ablation technology Ricardo Pérez, MD
Current Trends in Ventricular Tachycardia Ablation Daniel Arzola, MD
Safety of Catheter Ablation Procedures in the very elderly A. John Kadado, MD
Boston FIT
Q & A
11:30am
Satellite Symposium followed by Lunch
1:00pm
SESSION 3 CLINICAL EP
Management of Long QT Syndrome Héctor Banchs, MD
Evaluation and Management of Asymptomatic Bradycardia and Conduction Block Parikshit Sharma, MD
Syncope: evaluation and management Suleika Olivero, MD
Antiarrhythmic Therapy Do’s and Don’ts Hilton Franqui Rivera, MD
Q & A
3:00pm
Closing remarks Héctor J. Martínez González, MD FACC
This activity is sponsored by The Ponce Medical School Foundation, Inc. and the American College of Cardiology Puerto Rico Chapter.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Ponce Medical School Foundation, Inc and the American College of Cardiology Puerto Rico Chapter. The Ponce Medical School Foundation, Inc is accredited by the Accreditation Council for Continuing Medical Education (ACCME), Provider’s No. 0007249, to provide continuing medical education for physicians. The Ponce Medical School Foundation, Inc is accredited by the Puerto Rico Board of Licensing and Medical Disciplines, provider’s No. 016-DC23-JLDM.
Credit Designation
The Ponce Medical School Foundation, Inc designates this educational activity for a maximum of 5.0 AMA PRA Category 1 Credits™ subject to approval. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Policy
It is the policy of Ponce Medical School Foundation, Inc to ensure independence, balance, objectivity, scientific rigor and integrity in all of its sponsored educational activities.
All persons who are in a position to control the educational content of a sponsored activity are expected to disclose to the participants any relevant financial relationship(s) they and/or spouse/partner have with the commercial supporters and/or providers of commercial services and/or manufacturers of any commercial products discussed during the educational activity. All conflicts of interest have been identified and resolved prior to the release of this activity.
The faculty will report financial relationships or relationships to products or devices they or their spouse/partner have with commercial interests related to the content of this CME activity.
Target Audience
This CME activity has been designed for Physicians.
Cardiac electrophysiology has experienced growth in an exponential manner, we have moved from the implantation of very large and poorly powered pacemakers to the deployment of transvenously delivered MRI compatible miniaturized leadless capsules capable of pacing for decades, from the implantation of large epicardial defibrillating paddles around the heart to the implantation of totally subcutaneous systems, from performing electrophysiologic studies with primitive bipolar catheters to having almost automated three dimensional mapping systems capable of obtaining over 2000 arrhythmia points in just over 5 minutes.
Despite these advances, many patients continue to live with cardiac arrhythmias and patients continue to present to emergency rooms, internists and general cardiology and electrophysiologists offices with complex situations that require rapid recognition and treatment. This year summit’s objective is to update all of us, in the diagnosis and up to date management of conditions like supraventricular arrhythmias, ventricular tachycardia and atrial fibrillation as well as cardiac device management. We will review all recent updated guidelines on these topics and as usual, have sessions on basic electrocardiographic diagnosis of arrhythmias.
OBJECTIVES
Updates in Management of Atrial Fibrillation
How to proceed with anti-coagulation after left atrial appendage occlusion
Recommendation of management of subclinical and device-detected atrial fibrillation
Integration of wearable technology for arrhythmia detection
Updates in cardiac ablation technology
Review of cryoablation vs radiofrequency ablation pulmonary vein isolation
Appropriate risk Stratification for Sudden Cardiac Death in Athletes
Evaluation and Management of Asymptomatic Bradycardia and Conduction Blocks
Syncope: evaluation and management
Appropriate approach of anti-arrhythmic drugs use
TARGET AUDIENCE
This activity has been designed for internists, cardiology fellows, cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons involved in the management of cardiovascular diseases and any other physicians interested in the cardiology field.
Accreditation for this program is only approved for NURSES.
AACN Approval Notification of CNE Individual Activity
File Number: 24280
This nursing continuing professional individual activity is approved for 6.00 contact hours.
Approval for this activity begins 10/1/2022 and expires 2 years from this date.
This nursing continuing professional development activity was approved by the American Association of Critical-Care Nurses, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
As planning for a hybrid ACC.21 kicked into high gear last year, the College was hopeful that delaying the meeting until the Spring would allow an opportunity for ACC and its membership to safely reconnect in Atlanta, GA, for the 70th Annual Scientific Session & Expo. Unfortunately, with the continued presence of COVID-19 and a sudden, sharp increase in ongoing travel restrictions imposed by health care institutions, academic medical centers and exhibitor companies, the decision has had to be made to transition the meeting from a hybrid model to entirely virtual.
While we are saddened that we will need to wait another year before seeing everyone in person, plans for ACC.21 are continuing but as an all virtual experience! Building on the success of last year’s meeting, ACC.21 will be a world-class program delivered through an innovative digital platform built for learning, collaboration, and networking. ACC.21 will also offer a robust virtual Expo with both exhibits and education from our signature Learning Destinations and, last but not least, more opportunities for you to engage and interact with your colleagues from around the world.
Stay tuned for more details as the ACC.21 Program Committee works to finalize the line-up of sessions. For additional information, please review our FAQs, which will be updated as planning continues.
Thank you for all that you do every day to serve your patients and your communities and we look forward to reconnecting virtually with all of you in May.
FELLOWS IN TRAINING WIN FIRST ROUND OF JEOPARDY COMPETITION
We are excited with the news that our fellows in training have won the first round of the jeopardy. ACC National Competition and will be moving on to the 2nd round of competition. They are led by the one and only Dr. Hilton Franqui; current Cardiovascular Program Director for the University Hospital Fellowship, master of Jeopardy competition in local forums for many years and a member of the Board for the ACC Puerto Rico Chapter. We will continue to support current and future endeavors for our fellows as they are the bright future for continued enthusiasm and learning in Puerto Rico. My congratulations to all the attending physicians that continue to support training programs around the country.
ACC PR Chapter, no se solidariza con las expresiones vertidas por la señora Cecilia Furlán en representación de grupo “Médicos por la Verdad Puerto Rico”.
El Colegio Americano de Cardiología, capítulo de Puerto Rico (ACC-PR) no se solidariza con las expresiones vertidas por la señora Cecilia Furlán, en representación del grupo “Médicos por la Verdad Puerto Rico”. Furlán, quien según sus expresiones no es médico de profesión, ha estado brindando información que conduce a error y confusión, sobre la verdad de la pandemia de coronavirus; específicamente sobre su diagnóstico, manejo de salud pública sobre la protección y recomendaciones para evitar el contagio.
El capítulo de Puerto Rico del Colegio Americano de Cardiología avala la información oficial, basada en las guías del Colegio Americano de Cardiología y recomendaciones de las agencias federales que incluye el Centro de para el Control y la Prevención de Enfermedades (CDC), Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) y Organización Mundial de la Salud (OMS).